Tag: pharmaceuticals

Latest News

Rocket Pharmaceuticals Presents Promising Preliminary Results from Phase 1 Trial of Commercial-Grade RP-L102 “Process B” for Fanconi Anemia at 61st American Society of Hematology Annual Meeting

Newsemia
NEW YORK–(BUSINESS WIRE)–Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) (“Rocket”), a clinical-stage company advancing an integrated and sustainable pipeline of genetic therapies for rare childhood disorders, today...
Latest News

Website errors raise calls for Medicare to Be flexible with seniors’ enrollment

Newsemia
Beneficiaries are going to be able to change plans next year because of misinformation through the website for Medicare enrollment although officials provided few details....
Latest News

Aerie Pharmaceuticals Submits Marketing Authorisation Application for Roclanda® (netarsudil and latanoprost ophthalmic solution) 0.02%/0.005% in Europe

Newsemia
DURHAM, N.C.–(BUSINESS WIRE)–Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients...
Latest News

What will it take to improve recruitment for clinical trials?

Newsemia
Whether clinical trial travel requires a short rideshare trip or a flight halfway across the world, the key to keeping participants enrolled and engaged is...
Pediatrics

Teens with Heart Disease Improve Exercise Capacity in Large Clinical Trial

Newsemia
The largest-ever clinical trial of a medication for pediatric cardiology patients found that an oral drug significantly improved exercise capacity in adolescent patients with severe,...
Pediatrics

Understanding Transporter Proteins at a Single-Molecule Level

Newsemia
Research co-led by a St. Jude investigator and researchers from Columbia University and the New York State Psychiatric Institute reveals the mechanics of how some...
Latest News

Angion’s kidney therapy advances

Newsemia
The 28-patient study showed that Angion’s drug improved kidney function, based on patients’ estimated glomerular filtration rate (eGFR), a key renal function metric. Source link...
Latest News

Glutamine-blocking compound slows cancer growth, unleashes anti-tumor immune response

Newsemia
A compound developed by Johns Hopkins researchers that blocks glutamine metabolism can slow tumor growth, alter the tumor microenvironment and promote the production of durable...
Gastroenterology

HIMC at Mount Sinai to evaluate therapeutic effects of novel cancer immunotherapy

Newsemia
The Human Immune Monitoring Center at the Icahn School of Medicine at Mount Sinai will apply cutting-edge high-throughput technologies to evaluate the therapeutic effects of...

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy